Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2000-9-27
pubmed:abstractText
Overexpression of agouti-related peptide (AgRP), an endogenous melanocortin (MC) 3 and 4 receptor antagonist (MC3/4-R), causes obesity. Exogenous AgRP-(83---132) increases food intake, but its duration and mode of action are unknown. We report herein that doses as low as 10 pmol can have a potent effect on food intake of rats over a 24-h period after intracerebroventricular injection. Additionally, a single third ventricular dose as low as 100 pmol in rats produces a robust increase in food intake that persists for an entire week. AgRP-(83---132) completely blocks the anorectic effect of MTII (MC3/4-R agonist), given simultaneously, consistent with a competitive antagonist action. However, when given 24 h prior to MTII, AgRP-(83---132) is ineffective at reversing the anorectic effects of the agonist. These results support a critical role of MC tone in limiting food intake and indicate that the orexigenic effects of AgRP-(83---132) are initially mediated by competitive antagonism at MC receptors but are sustained by alternate mechanisms.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Agouti-Related Protein, http://linkedlifedata.com/resource/pubmed/chemical/Appetite Stimulants, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Melanocortin, Type 3, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Melanocortin, Type 4, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Corticotropin, http://linkedlifedata.com/resource/pubmed/chemical/acetyl-norleucyl(4)-(aspartyl(5)-his..., http://linkedlifedata.com/resource/pubmed/chemical/alpha-MSH
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0363-6119
pubmed:author
pubmed:issnType
Print
pubmed:volume
279
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
R47-52
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10896863-Agouti-Related Protein, pubmed-meshheading:10896863-Animals, pubmed-meshheading:10896863-Appetite Stimulants, pubmed-meshheading:10896863-Body Weight, pubmed-meshheading:10896863-Dose-Response Relationship, Drug, pubmed-meshheading:10896863-Eating, pubmed-meshheading:10896863-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:10896863-Oligopeptides, pubmed-meshheading:10896863-Peptide Fragments, pubmed-meshheading:10896863-Proteins, pubmed-meshheading:10896863-Rats, pubmed-meshheading:10896863-Rats, Long-Evans, pubmed-meshheading:10896863-Receptor, Melanocortin, Type 3, pubmed-meshheading:10896863-Receptor, Melanocortin, Type 4, pubmed-meshheading:10896863-Receptors, Corticotropin, pubmed-meshheading:10896863-Time, pubmed-meshheading:10896863-alpha-MSH
pubmed:year
2000
pubmed:articleTitle
Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade.
pubmed:affiliation
Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0559, USA. haganmm@email.uc.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.